Veracyte | VCYT - 资产



金融业
股票价格
USD
资产
USD 1.49B
现金及等价物
USD 299.52M
销售成本
USD 42.19M
流动资产
USD 574.78M
流动负债
USD 62.74M
债务
USD 39.33M
EBIT
USD 23.96M
EBITDA
USD 43.96M
员工
824
EPS每股收益
USD 0.54
股本和储备
USD 1.39B
销售毛利
USD 108.55M
债务利息支出
USD 2K
利息收入
USD 3.48M
贷款资金
USD 0
市值
USD 3.62B
净收入
USD 25.49M
营业费用
USD 126.36M
营业利润
USD 23.96M
普通股股本
USD 79.79M
PE价格收益
42.77
税前利润
USD 26.52M
销售收入
USD 150.32M
销售和管理费用
USD 55.71M
股票
USD 22.66M
贸易债权人
USD 8.02M
应收帐款人
USD 54.18M


资产 更改 日
Agenus USD 172.69M 13.76M 2026-06
Agilent USD 13.07B 252M 2026-03
Anika Therapeutics USD 183.47M 4.09M 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
Bruker USD 6.05B 77.8M 2026-06
Heron Therapeutics USD 246.22M 9.66M 2026-03
Illumina USD 6.65B 91M 2026-06
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Laboratory Of America USD 18.53B 554.8M 2026-06
Ligand Pharmaceuticals USD 2.19B 653.77M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Siemens EUR 167.54B 428M 2026-06
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Veracyte USD 1.49B 49.97M 2026-06
Waters USD 24.75B 220M 2026-06